6
Views
2
CrossRef citations to date
0
Altmetric
Original Article

p-Fluoro-hexahydro-sila-difenidol Exhibits Poor Selectivity between M3 and M1 Muscarinic Receptors

, &
Pages 293-300 | Received 30 Jan 1992, Accepted 04 Mar 1992, Published online: 09 Jul 2009

References

  • Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 1959; 14: 48–58
  • Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987; 237: 527–532
  • Bonner T.I., Young A.C., Brann M.R., Buckley N.J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1988; 1: 403–410
  • Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 1991; 256: 727–733
  • Eglen R.M., Michel A.D., Montgomery W.W., Kunysz E.A., Machado C.A., Whiting R.L. The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro. Br. J. Pharmacol. 1990; 99: 637–642
  • Hu J., El-Fakahany E.E. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors. Mol. Pharmacol. 1990; 38: 895–903
  • Hulme E.C., Birdsall N.J.M., Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 1990; 30: 633–673
  • Kromer W., Baron E., Beinborn M., Boer R., Eltze M. Characterization of the muscarinic receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach. Naunyn. Schmiedebergs Arch. Pharmakol. 1990; 34: 165–170
  • Lambrecht G., Feifel R., Forth B., Strohmann C., Tacke R., Mutschler E. p-Fluoro-hexahydro-sila-difenidol: The first M2β-selective muscarinic antagonist. Eur. J. Pharmacol. 1988; 152: 193–194
  • Lambrecht G., Feifel R., Wagner-Roeder M., Strohmann C., Zilch H., Tacke R., Waelbroeck M., Christophe J., Boddeke H., Mutschler E. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur. J. Pharmacol. 1989; 168: 71–80
  • Mitchelson F., Choo L.K., Darroch S. Muscarinic receptor differentiation. Clin. Exp. Pharmacol. Physiol. 1989; 16: 523–528
  • Munson R.J., Rodbard D. Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 202–239
  • Nathanson N.M. Molecular properties of the muscarinic acetylcholine receptor. Annu. Rev. Neurosci. 1987; 10: 195–236
  • Pedder E.K., Eveleigh P., Poyner D., Hulme E.C., Birdsall N.J.M. Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br. J. Pharmacol. 1991; 103: 1561–1567
  • Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J., Capon D.J. Distinct primary structure, ligand binding properties and tissuespecific expression of four human muscarinic acetylcholine receptors. EMBO J. 1987; 6: 3923–3929
  • Poyner D.R., Birdsall N.J.M., Curtis C., Eveleigh P., Hulme E.C., Pedder E.K., Wheatley M. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamindopropyl)dimethylammonio-2-hydroxyl-1-propanesulfonate. Mol. Pharmcol. 1989; 36: 420–429
  • Ransom J.T., Cher H.M., Delmendo R.E., Sharif N.A., Eglen R. Characterization of the m4 muscarinic receptor Ca2+ response in a subclone of PC-12 cells by single cell flow cytometry. J. Biol. Chem. 1991; 266: 11738–11745
  • Richards M.H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem. Pharmacol. 1991; 42: 1645–1653

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.